Cargando…
For which lung cancer patients is re-administration of immune checkpoint inhibitors effective?
Objective: Currently, immune checkpoint inhibitors (ICIs) play a central role in the treatment of lung cancer. However, ICI re-administration is still uncommon, and its utility should be evaluated as early as possible. Patients and Methods: Twenty-five patients who received ICIs twice or more in any...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Japanese Association of Rural Medicine
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8527621/ https://www.ncbi.nlm.nih.gov/pubmed/34707736 http://dx.doi.org/10.2185/jrm.2021-025 |